Vasopressors in sepsis: Do they change the outcome?

Marco A. González, Cristhiaan D. Ochoa

    Resultado de la investigación: Capítulo del libro/informe/acta de congresoCapítulorevisión exhaustiva

    Resumen

    The final event in septic shock is multiorgan failure syndrome as a consequence of hypoperfusion resulting from a late, refractory vasodilatory shock. Before starting vasoactive agents, the underlying infectious disease must be under treatment, the volume status aggressively corrected, the immunomodulatory therapy started, and adrenal gland failure ruled out. NE is the vasoactive agent with the best results in refractory shock, and it is probably the vasoconstrictor that most improves mortality in septic patients. VP levels are depleted in the late phase of septic shock. If the patient is hypotensive, even though vasoactive agents and inotropes are used, VP should be started at low doses.

    Idioma originalInglés
    Título de la publicación alojadaSepsis (Second Edition)
    EditorialSpringer New York
    Páginas121-125
    Número de páginas5
    ISBN (versión impresa)0387298169, 9780387298160
    DOI
    EstadoPublicada - 2006

    Huella

    Profundice en los temas de investigación de 'Vasopressors in sepsis: Do they change the outcome?'. En conjunto forman una huella única.

    Citar esto